109 related articles for article (PubMed ID: 6992759)
1. Free insulin, C-peptide and glucagon profiles in insulin dependent diabetes mellitus.
Scott RS; Espiner EA; Donald RA; Ellis MJ
Aust N Z J Med; 1980 Apr; 10(2):146-50. PubMed ID: 6992759
[TBL] [Abstract][Full Text] [Related]
2. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
Giugliano D; Luyckx AS; Lefebvre PJ
J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
[TBL] [Abstract][Full Text] [Related]
4. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.
Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S
Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972
[TBL] [Abstract][Full Text] [Related]
6. Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetics: comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy.
Gerbitz KD; Kemmler W; Edelmann A; Summer J; Mehnert H; Wieland OH
Eur J Clin Invest; 1979 Dec; 9(6):475-83. PubMed ID: 119646
[TBL] [Abstract][Full Text] [Related]
7. Residual pancreatic function in insulin dependent diabetics.
Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA
Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357
[TBL] [Abstract][Full Text] [Related]
8. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
[TBL] [Abstract][Full Text] [Related]
9. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
[TBL] [Abstract][Full Text] [Related]
10. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
[TBL] [Abstract][Full Text] [Related]
11. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects.
Sgambato S; Passariello N; Giugliano D; Torella R; D'Onofrio F
Acta Diabetol Lat; 1981; 18(3):235-41. PubMed ID: 7029989
[TBL] [Abstract][Full Text] [Related]
12. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.
Wurzburger MI; Prelevic GM; Sönksen PH; Balint-Peric LA; Wheeler M
J Clin Endocrinol Metab; 1993 Jul; 77(1):267-72. PubMed ID: 8325951
[TBL] [Abstract][Full Text] [Related]
13. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
Ferrero E; Casale G; Tassi G; Ciaponi A
Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
[TBL] [Abstract][Full Text] [Related]
14. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
Frier BM; Ashby JP; Nairn IM; Baird JD
Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
[TBL] [Abstract][Full Text] [Related]
15. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
[TBL] [Abstract][Full Text] [Related]
18. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.
Nauck MA; Wollschläger D; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Willms B
Diabetologia; 1996 Dec; 39(12):1546-53. PubMed ID: 8960841
[TBL] [Abstract][Full Text] [Related]
19. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
[TBL] [Abstract][Full Text] [Related]
20. Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.
Starke A; Keck E; Berger M; Zimmermann H
Diabetologia; 1981 May; 20(5):547-52. PubMed ID: 7026328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
